Hypomethylation of DNA: An epigenetic mechanism involved in tumor promotion

Molecular Carcinogenesis

Volumn 11, Issue 4, 1994, Pages 185-188

  Counts, Jennifer L ^a   Goodman, Jay I ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Carcinogenesis; Cell proliferation; DNA methylation; epigenetic; hypomethylation; promotion; risk assessment

Indexed keywords

CARCINOGENESIS; DNA METHYLATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TUMOR PROMOTION;

ANIMAL; DNA; DNA, NEOPLASM; GENE EXPRESSION; METHYLATION; MICE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; ONCOGENES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028559017     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.2940110402     Document Type: Article

References (51)

1. The inheritance of epigenetic defects
2. Mechanisms for the control of gene activity during development
3. The role of DNA methylation in cancer
4. DNA methylation and chromatin structure
5. DNA methylation and gene expression
6. An MDBP site in the first intron of the human c‐myc gene
7. DNA methylation inhibits transcription indirectly via a methyl‐CpG binding protein
8. Transcriptional repression by methylation of CpG
9. Altered methylation of ras oncogenes in benzidine‐induced B6C3F1 mouse live4 tumors
10. Maternal‐specific methylation of the imprinted mouse lgf2r locus identifies the expressed locus as carrying the imprinting signal
11. Increased mannose‐6‐phosphate/insulin‐like growth factor II receptor and transforming growth factor β1 levels during monoterpene‐induced regression of mammary tumors
12. 5‐Methylcytosine content of nuclear DNA during chemical hepatocarcinogenesis and in carcinomas which result
13. DNA methylation and methylase levels in normal and melignant mouse hepatic tissue
14. Genetic alterations during colorectal tumor development
15. The 5‐methyl cytosine content of DNA From human tumors
16. The tumorigenicity of 5‐azacytidine in the male Fischer rat
17. Development of resistance to the growth inhibitory effects of transforming growth factor beta‐1 during the spontaneous transformation of rat liver epithelial cells
18. Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5‐aza‐2‐deoxytidine
19. Mouse liver carcinogenesis: Mechanisms and relevance
20. Hypomethylation of DNA: A possible nongenotoxic mechanism underlying the role of cell proliferation in carcinogenesis
21. Alterations in the methylation status and expression of the raf oncogene in phenobarbital‐induced and spontaneous B6C3F1 mouse liver tumors
22. Comparative analysis of the 5′ flanking region of Ha‐ras in B6C3F1, C3H/He and C57BL/6 mouse liver
23. Ras gene amplification and malignant transformation
24. In vitro and in vivo regulation of liver epithelial cells carrying a metallothionein‐ras T24 fusion gene
25. Different levels of v‐Ha‐ras p21 expression in primary keratinocytes transformed with Harvey sarcoma virus correlate with benign versus malignant behavior
26. Predisposition to neoplastic transformation caused by gene replacement of H‐ras1
27. DNA hypermethylation is associated with 17p allelic loss in neural tumors
28. Regional hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors
29. The rate of hydrolytic deamination of 5‐methylcytosine in double‐stranded DNA
30. 5‐Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes
31. Choline deficiency, partial hepatectomy, and liver tumors in rats and mice
32. Hepatocarcinogen‐esis in rats fed methyl‐deficient, amino acid‐defined diets
33. The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens
34. The effect of choline and methionine deficiencies on the number and volume percentage of altered hepatic foci in the presence of absence of diethylnitrosamine initiation in rat liver
35. Probable free radical effects on rat liver nuclei during early hepatocarcinogenesis with a choline‐devoid low‐methionine diet
36. Tumorigenesis, protooncogene activation, and other gene abnormalities in methyl deficiency
37. Methyl groups in carcinogenesis: Effects on DNA methylation and gene expression
38. Methyl deficiency, DNA methylation and cancer: Studies on the reversibility of the effects a lipotrope of a lipotrope‐deficient diet
39. Altered expression of retrovirus‐like sequences and cellular oncogenes in mice fed methyl‐deficient diets
40. Substrate and sequence specificity of a eukaryotic DNA methylase
41. Nucleoside monophosphate kinase may be the key enzyme preventing salvage of DNA 5‐methylcytosine
42. Enzymatic removal of 5‐methylcytosine from DNA by a human DNA‐glycosylase
43. Genetic errors, cell proliferation and carcinogenesis
44. Chemical carcinogenesis: Too many rodent carcinogens
45. Rapid growth of preneoplastic lesions in hepatocarcinogen‐sensitive C3H/HeJ male mice relative to C57BL/6J male mice
46. 6‐methylguanine residues
47. 6‐methylguanine‐DNA methyltransferase by 5‐methylcytosine
48. DNA methylation patterns: An additional level of information?
49. The initiation‐promotion‐progression model of rat hepatocarcingoenesis
50. A rational Approach to risk assessment requires the use of biological information: An analysis of the National Toxicology Program (NTP), final report of the advisory review by the NTP Board of Scientific Counselors